Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
BPH Global Registry
NCT05543200 · View on ClinicalTrials.gov ↗
Study Summary
Benign prostatic hyperplasia (BPH) is one of the most common performed surgical procedures in urology. Over the past few decades there have been an increasing development of newer surgical treatment options. Additionally, the outcome parameters for BPH treatments have been standardized. While data are available for the initial pivotal studies, post-market release data are lacking. Under the umbrella of uCARE, we have started a prospective, ongoing international registry for recording demographics and outcomes for patients undergoing surgical treatments for BPH.
Conditions Studied
Study Locations (20)
Other
- Hospital Dr. Juan Morey La Unión — La Unión
- Hospital del Trabajador — Santiago
- The First Affiliated Hospital, Zhejiang University School of Medicine — Hangzhou
- University of Cyprus — Nicosia
- Shariati Hospital — Tehran
- University of Basrah — Basra
- Azienda Ospedaliero-Universitaria Careggi — Florence
- Sapienza University of Rome, Division of Urology, Ospedale Sant'Andrea — Rome
- American University of Beirut — Beirut
- Universiti Malaya — Kuala Lumpur
- Kati University Hospital — Kati
- Centro Medico Nacional Siglo XXI — Mexico City
- Benue State University Teaching Hospital, Department of Surgery — Makurdi
- Ahmadu Bello University Teaching Hospital — Zaria
- Institute of Kidney Diseases Peshawar — Peshawar
- Lady Reading Hospital — Peshawar
- Hamad Medical Corporation Qatar — Doha
California
- Keck Medicine of USC — Los Angeles
Ontario
- Toronto Western Hospital, University Health Network — Toronto
Quebec
- McGill University Health Centre — Montreal
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7,500 participants |
| Start Date | 2023-03-13 |
| Est. Completion | 2027-03 |
Interested in This Trial?
Always speak with your doctor before enrolling in a clinical trial.
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05543200
The ClinicalTrials.gov registry entry for NCT05543200 describes a study currently listed as recruiting. It is categorized as an unspecified phase, which is the standard way researchers label where a study sits along the investigational pathway from early safety work through later efficacy and post-marketing evaluation. The registered enrollment target is 7,500 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Société Internationale d'Urologie, which has 1 total studies on file at ClinicalTrials.gov, and sponsors are the parties responsible for study design, oversight, and regulatory filings.
The record links to 2 conditions, with Benign Prostatic Hyperplasia appearing as the primary indexed condition, and to 0 interventions. Interventions can include drugs, devices, procedures, behavioral programs, or observational arms, and each is tracked as a separate registry field so that downstream queries can filter accurately. When a trial lists multiple interventions, it usually reflects a multi-arm design or a comparison protocol rather than a single treatment being tested in isolation. The brief summary published in the registry is the clearest source of protocol intent and should be read before drawing conclusions from any sidebar tags.
Geographic footprint matters for practical reasons: NCT05543200 reports 20 study locations spanning 4 distinct geographic areas — top geographies include Other, California, Ontario. A larger site network tends to correlate with broader recruitment capacity, but it does not imply anything about study quality, and site-level enrollment status can diverge from the overall registry status shown above. Every data point on this page comes from the public ClinicalTrials.gov dataset and is reproduced here for reference only; it is not a medical recommendation, an endorsement of the sponsor, or an invitation to enroll. Verify current status, eligibility criteria, and contact details directly at ClinicalTrials.gov, and discuss any participation decision with your own healthcare provider.
Frequently Asked Questions
What is clinical trial NCT05543200 about?
NCT05543200 is a clinical study titled "BPH Global Registry". Benign prostatic hyperplasia (BPH) is one of the most common performed surgical procedures in urology. Over the past few decades there have been an increasing development of newer surgical treatment options. Additionally, the outcome parameters for BPH treatments have been standardized. While data a...
What is the current status of trial NCT05543200?
This trial is currently recruiting. The enrollment target is 7,500 participants. The study started on 2023-03-13. Estimated completion is 2027-03.
What conditions does trial NCT05543200 study?
This clinical trial studies the following conditions: Benign Prostatic Hyperplasia, Lower Urinary Tract Symptoms. These conditions were identified from the trial registry and reflect the primary focus areas of the research.
Who is sponsoring clinical trial NCT05543200?
This trial is sponsored by Société Internationale d'Urologie, which has 1 total clinical trials registered on ClinicalTrials.gov. The sponsor is responsible for the study's design, funding, and regulatory compliance.
Where is trial NCT05543200 being conducted?
This trial has 20 study locations across California, Ontario, Quebec. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How Clinical Trials Work
Understand phases 1-4, trial design, randomization, and the informed consent process.
Patient Rights in Clinical Trials
Your rights as a participant: consent, withdrawal, privacy, and who to contact.
Finding the Right Clinical Trial
A practical guide to searching trials, understanding eligibility, and evaluating options.
All Guides
Browse our complete library of clinical trial educational resources.
Read our methodology — how this data is sourced, computed, and verified.